Evidence map›Paper›PMID 41034300›Full record

ArticleNPJ Parkinson's disease2025

Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and older.

Kerri A Pierz, Whitley Aamodt, Caroline Gochanour, Ryan Kurth, Michael C Brumm, Christopher S Coffey, Laura E Heathers, Michelle Totten, Richard L Doty, Kenneth Marek and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05065060 (Parkinson's Progression Markers Initiative Online Study), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05065060 recruitingnot on this map

Parkinson's Progression Markers Initiative Online Study (PPMI Online)

TypeobservationalSponsorMichael J. Fox Foundation for Parkinson's ResearchRan2021 to 2041Enrolled500,000ConditionsParkinson DiseaseArmsObservation
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kerri A PierzElucidate Health, LLC, Brookfield, CT, USA. kerri@elucidatehealth.com.
Whitley AamodtDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Caroline GochanourDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
Ryan KurthDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
Michael C BrummDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
Christopher S CoffeyDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
Laura E HeathersDepartment of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA.
Michelle TottenDepartment of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA.
Richard L DotyDepartment of Otolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Kenneth MarekInstitute for Neurodegenerative Disorders, New Haven, CT, USA.
Andrew SiderowfDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Parkinson’s Progression Markers Initiative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study goal was to use a very large study cohort to establish normative data for the revised UPSIT (UPSIT-R) and to compare the resultant percentiles to those of the original UPSIT. A second study was performed to compare the performance of these two tests in a cohort of persons with and without Parkinson's disease (PD). UPSIT-R percentiles were derived by age and sex in 16,972 volunteers. Non-parametric statistics were employed to compare the results of those with and without PD. UPSIT-R performance declined with increasing age; deficits were more pronounced in men than women. The magnitude of the difference between the original and revised test percentile scores differed by age and sex. Olfactory deficits in PD were confirmed on the UPSIT-R. This study provides normative data clinically useful for assessing the relative degree of dysfunction in persons 60 years of age and older using the UPSIT-R. Trial Registration Information: ClinicalTrials.gov NCT05065060 .

Identifiers

PMID41034300
PMCPMC12488959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.